Rockwell Medical (RMTI) Assets Average (2011 - 2026)
Rockwell Medical's (RMTI) quarterly Assets Average came in at $57.3 million in Q1 2026, up 1.24% YoY from $56.6 million in Q1 2025, and little changed on a QoQ basis from $57.3 million in Q4 2025.
Rockwell Medical (RMTI) Assets Average (2011 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 16 years of Assets Average data on file, last reported at $57.3 million in Q1 2026.
- Quarterly Assets Average rose 1.24% year-over-year to $57.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $57.3 million (up 1.24% YoY) and the FY2025 annual result came in at $58.2 million, up 4.46% from the prior year.
- Assets Average was little changed at $57.3 million in Q1 2026, from $57.3 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $58.1 million in Q4 2024 to a low of $39.3 million in Q2 2023.
- A 5-year average of $51.5 million and a median of $52.4 million in 2023 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average slumped 41.57% — and 2024, when it surged 32.15%.
- Tracing RMTI's Assets Average over 5 years: stood at $50.4 million in 2022, then rose by 3.93% to $52.4 million in 2023, then gained by 10.99% to $58.1 million in 2024, then decreased by 1.43% to $57.3 million in 2025, then declined by 0.05% to $57.3 million in 2026.
- The last three Assets Average figures came in at $57.3 million (Q1 2026), $57.3 million (Q4 2025), and $55.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 5.97 Bn |
| 10 | Rockwell Medical | 30.62 Mn | 5.82 Mn | 3.24 Mn | 56.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.97 Mn |
| Mar 31, 2026 | 57.28 Mn |
| Dec 31, 2025 | 57.32 Mn |
| Sep 30, 2025 | 55.06 Mn |
| Jun 30, 2025 | 53.29 Mn |
| Mar 31, 2025 | 56.58 Mn |
| Dec 31, 2024 | 58.15 Mn |
| Sep 30, 2024 | 55.06 Mn |
| Jun 30, 2024 | 51.88 Mn |
| Mar 31, 2024 | 51.45 Mn |
| Dec 31, 2023 | 52.39 Mn |
| Sep 30, 2023 | 45.32 Mn |
| Jun 30, 2023 | 39.25 Mn |
| Mar 31, 2023 | 43.55 Mn |
| Dec 31, 2022 | 50.41 Mn |
| Sep 30, 2022 | 56.65 Mn |
| Jun 30, 2022 | 48.28 Mn |
| Mar 31, 2022 | 43.01 Mn |
| Dec 31, 2021 | 53.64 Mn |
| Sep 30, 2021 | 61.19 Mn |